Mohammad Zagzoog, Ewa Tuleja, Ulrique Michon-Pasturel, Benoît Boura, Romain De Blic, Lucie Derycke, Alexandros Mallios, Maxime Raux, Yann Gouëffic
{"title":"动脉血运重建术后的临床改善与运动血氧测定结果相关。","authors":"Mohammad Zagzoog, Ewa Tuleja, Ulrique Michon-Pasturel, Benoît Boura, Romain De Blic, Lucie Derycke, Alexandros Mallios, Maxime Raux, Yann Gouëffic","doi":"10.1177/1358863X251313964","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> Exercise transcutaneous oximetry (Ex-TcpO2) is used to support the vascular origin of lower-limb pain, or to assess walking impairment. The aim of this study was to describe the association between Ex-TcpO2 measurement and the perioperative clinical and morphological outcomes after revascularization in patients with intermittent claudication (IC). <b>Methods:</b> From January to December 2022, a single-center prospective observational study was conducted among patients with IC. Patients were referred by vascular surgeons for Ex-TcpO2 for doubtful arterial origin. Perioperative clinical and morphological outcomes were assessed by the Rutherford-Becker classification and duplex ultrasound examination. The primary patency rate and primary sustained clinical improvement were evaluated at 1 month after revascularization. <b>Results:</b> Eighty-two patients (64% men) underwent Ex-TcpO2 and were enrolled in the study, of whom 65% were category III of the Rutherford classification. Indications for Ex-TcpO2 were to assess the origin of the IC symptoms in 65%. Sixty-seven (81%) patients had positive Ex-TcpO2, and 15 (18%) had negative Ex-TcpO2. Patients with positive Ex-TcpO2 were older (65 ± 13 vs 58 ± 20, <i>p</i> = 0.43), and had a significantly lower ankle-brachial index (ABI) compared to the negative group (0.65 ± 0.22 vs 0.92 ± 0.22, <i>p</i> < 0.001) as well as a lower maximum walking distance (MWD) (200 m [150, 300] vs 525 m [500, 872], <i>p</i> < 0.001). Forty-two patients underwent revascularization (Ex-TcpO2 positive [<i>n</i> = 35/67]; Ex-TcpO2 negative [<i>n</i> = 7/15]). Revascularization technical success and primary patency rate were 100% in both groups. Clinical improvement was significantly greater in the Ex-TcpO2 positive group (97% [<i>n</i> = 34/35] vs 0% [<i>n</i> = 0/7], <i>p</i> < 0.001). Multivariate analysis shows a positive association between pain at the buttock and the decrease from rest of oxygen pressure (DROP) ≤ -15 mmHg at the level of the buttock with the presence of iliac lesions. <b>Conclusion:</b> On a routine basis, Ex-TcpO2 is a tool of interest to assess patients with claudication for doubtful arterial origin or walking distance, especially in proximal IC, and to predict favorable clinical outcomes after revascularization.</p>","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"147-154"},"PeriodicalIF":3.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical improvement after arterial revascularization is associated with exercise oximetry results.\",\"authors\":\"Mohammad Zagzoog, Ewa Tuleja, Ulrique Michon-Pasturel, Benoît Boura, Romain De Blic, Lucie Derycke, Alexandros Mallios, Maxime Raux, Yann Gouëffic\",\"doi\":\"10.1177/1358863X251313964\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Introduction:</b> Exercise transcutaneous oximetry (Ex-TcpO2) is used to support the vascular origin of lower-limb pain, or to assess walking impairment. The aim of this study was to describe the association between Ex-TcpO2 measurement and the perioperative clinical and morphological outcomes after revascularization in patients with intermittent claudication (IC). <b>Methods:</b> From January to December 2022, a single-center prospective observational study was conducted among patients with IC. Patients were referred by vascular surgeons for Ex-TcpO2 for doubtful arterial origin. Perioperative clinical and morphological outcomes were assessed by the Rutherford-Becker classification and duplex ultrasound examination. The primary patency rate and primary sustained clinical improvement were evaluated at 1 month after revascularization. <b>Results:</b> Eighty-two patients (64% men) underwent Ex-TcpO2 and were enrolled in the study, of whom 65% were category III of the Rutherford classification. Indications for Ex-TcpO2 were to assess the origin of the IC symptoms in 65%. Sixty-seven (81%) patients had positive Ex-TcpO2, and 15 (18%) had negative Ex-TcpO2. Patients with positive Ex-TcpO2 were older (65 ± 13 vs 58 ± 20, <i>p</i> = 0.43), and had a significantly lower ankle-brachial index (ABI) compared to the negative group (0.65 ± 0.22 vs 0.92 ± 0.22, <i>p</i> < 0.001) as well as a lower maximum walking distance (MWD) (200 m [150, 300] vs 525 m [500, 872], <i>p</i> < 0.001). Forty-two patients underwent revascularization (Ex-TcpO2 positive [<i>n</i> = 35/67]; Ex-TcpO2 negative [<i>n</i> = 7/15]). Revascularization technical success and primary patency rate were 100% in both groups. Clinical improvement was significantly greater in the Ex-TcpO2 positive group (97% [<i>n</i> = 34/35] vs 0% [<i>n</i> = 0/7], <i>p</i> < 0.001). Multivariate analysis shows a positive association between pain at the buttock and the decrease from rest of oxygen pressure (DROP) ≤ -15 mmHg at the level of the buttock with the presence of iliac lesions. <b>Conclusion:</b> On a routine basis, Ex-TcpO2 is a tool of interest to assess patients with claudication for doubtful arterial origin or walking distance, especially in proximal IC, and to predict favorable clinical outcomes after revascularization.</p>\",\"PeriodicalId\":23604,\"journal\":{\"name\":\"Vascular Medicine\",\"volume\":\" \",\"pages\":\"147-154\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vascular Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/1358863X251313964\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/24 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/1358863X251313964","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
运动经皮血氧仪(Ex-TcpO2)用于支持下肢疼痛的血管起源,或评估行走障碍。本研究的目的是描述Ex-TcpO2测量与间歇性跛行(IC)患者血运重建术后围手术期临床和形态学结果之间的关系。方法:从2022年1月至12月,在IC患者中进行了一项单中心前瞻性观察研究。患者因可疑的动脉来源而被血管外科医生转诊为Ex-TcpO2。采用Rutherford-Becker分型及双工超声检查评估围手术期临床及形态学结果。在血运重建术后1个月评估原发性通畅率和原发性持续临床改善情况。结果:82例患者(64%男性)接受了Ex-TcpO2治疗并纳入研究,其中65%为Rutherford分类的III类。Ex-TcpO2的适应症是评估65%的IC症状的起源。67例(81%)患者Ex-TcpO2阳性,15例(18%)患者Ex-TcpO2阴性。Ex-TcpO2阳性患者年龄较大(65±13 vs 58±20,p = 0.43),踝肱指数(ABI)明显低于阴性组(0.65±0.22 vs 0.92±0.22,p < 0.001),最大步行距离(MWD)较低(200 m [150,300] vs 525 m [500,872], p < 0.001)。42例患者行血运重建术(Ex-TcpO2阳性[n = 35/67];Ex-TcpO2阴性[n = 7/15])。两组血运重建术成功率和初级通畅率均为100%。Ex-TcpO2阳性组的临床改善显著高于对照组(97% [n = 34/35] vs 0% [n = 0/7], p < 0.001)。多变量分析显示,当存在髂病变时,臀部疼痛与静息氧压(DROP)下降≤-15 mmHg呈正相关。结论:在常规基础上,Ex-TcpO2是评估动脉来源或步行距离可疑的跛行患者(特别是近端IC)的有用工具,并预测血运重建术后的良好临床结果。
Clinical improvement after arterial revascularization is associated with exercise oximetry results.
Introduction: Exercise transcutaneous oximetry (Ex-TcpO2) is used to support the vascular origin of lower-limb pain, or to assess walking impairment. The aim of this study was to describe the association between Ex-TcpO2 measurement and the perioperative clinical and morphological outcomes after revascularization in patients with intermittent claudication (IC). Methods: From January to December 2022, a single-center prospective observational study was conducted among patients with IC. Patients were referred by vascular surgeons for Ex-TcpO2 for doubtful arterial origin. Perioperative clinical and morphological outcomes were assessed by the Rutherford-Becker classification and duplex ultrasound examination. The primary patency rate and primary sustained clinical improvement were evaluated at 1 month after revascularization. Results: Eighty-two patients (64% men) underwent Ex-TcpO2 and were enrolled in the study, of whom 65% were category III of the Rutherford classification. Indications for Ex-TcpO2 were to assess the origin of the IC symptoms in 65%. Sixty-seven (81%) patients had positive Ex-TcpO2, and 15 (18%) had negative Ex-TcpO2. Patients with positive Ex-TcpO2 were older (65 ± 13 vs 58 ± 20, p = 0.43), and had a significantly lower ankle-brachial index (ABI) compared to the negative group (0.65 ± 0.22 vs 0.92 ± 0.22, p < 0.001) as well as a lower maximum walking distance (MWD) (200 m [150, 300] vs 525 m [500, 872], p < 0.001). Forty-two patients underwent revascularization (Ex-TcpO2 positive [n = 35/67]; Ex-TcpO2 negative [n = 7/15]). Revascularization technical success and primary patency rate were 100% in both groups. Clinical improvement was significantly greater in the Ex-TcpO2 positive group (97% [n = 34/35] vs 0% [n = 0/7], p < 0.001). Multivariate analysis shows a positive association between pain at the buttock and the decrease from rest of oxygen pressure (DROP) ≤ -15 mmHg at the level of the buttock with the presence of iliac lesions. Conclusion: On a routine basis, Ex-TcpO2 is a tool of interest to assess patients with claudication for doubtful arterial origin or walking distance, especially in proximal IC, and to predict favorable clinical outcomes after revascularization.
期刊介绍:
The premier, ISI-ranked journal of vascular medicine. Integrates the latest research in vascular biology with advancements for the practice of vascular medicine and vascular surgery. It features original research and reviews on vascular biology, epidemiology, diagnosis, medical treatment and interventions for vascular disease. A member of the Committee on Publication Ethics (COPE)